# Leptospira pathophysiology: into the storm of cytokines

Julie Cagliero, Sharon Yvette Angelina Manalo Villanueva, Mariko Matsui

► To cite this version:

Julie Cagliero, Sharon Yvette Angelina Manalo Villanueva, Mariko Matsui. Leptospira pathophysiology: into the storm of cytokines. Frontiers in Cellular and Infection Microbiology, 2018, 8, pp.204 - 204. 10.3389/fcimb.2018.00204. pasteur-01812933

HAL Id: pasteur-01812933

https://riip.hal.science/pasteur-01812933

Submitted on 12 Jun 2018

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

Check for
updates

# Leptospirosis Pathophysiology: Into the Storm of Cytokines

Julie Cagliero¹, Sharon Y. A. M. Villanueva² and Mariko Matsui¹*

¹Group Immunity and Inflammation, Institut Pasteur International Network, Institut Pasteur in New Caledonia, Nouméa, New Caledonia, ²Department of Medical Microbiology, College of Public Health, University of the Philippines, Manila, Philippines

Leptospirosis is a neglected tropical zoonosis caused by pathogenic spirochetes of the genus *Leptospira*. Infected reservoir animals, typically mice and rats, are asymptomatic, carry the pathogen in their renal tubules, and shed pathogenic spirochetes in their urine, contaminating the environment. Humans are accidental hosts of pathogenic *Leptospira*. Most human infections are mild or asymptomatic. However, 10% of human leptospirosis cases develop into severe forms, including high leptospiremia, multi-organ injuries, and a dramatically increased mortality rate, which can relate to a sepsis-like phenotype. During infection, the triggering of the inflammatory response, especially through the production of cytokines, is essential for the early elimination of pathogens. However, uncontrolled cytokine production can result in a cytokine storm process, followed by a state of immunoparalysis, which can lead to sepsis and associated organ failures. In this review, the involvement of cytokine storm and subsequent immunoparalysis in the development of severe leptospirosis in susceptible hosts will be discussed. The potential contribution of major pro-inflammatory cytokines in the development of tissue lesions and systemic inflammatory response, as well as the role of anti-inflammatory cytokines in contributing to the onset of a deleterious immunosuppressive cascade will also be examined. Data from studies comparing susceptible and resistant mouse models will be included. Lastly, a concise discussion on the use of cytokines for therapeutic purposes or as biomarkers of leptospirosis severity will be provided.

**Keywords:** *Leptospira*, leptospirosis, inflammatory response, cytokine storm, immunoparalysis, susceptible/resistant hosts

**OPEN ACCESS**

**Edited by:**

Elsio Augusto Wunder Jr.,
Yale University, United States

**Reviewed by:**

Maria Gomes-Solecki,
University of Tennessee Health
Science Center, United States
Lourdes Isaac,
Universidade de São Paulo, Brazil

*Correspondence:*

Mariko Matsui
mmatsui@pasteur.nc

**Received:** 28 February 2018

**Accepted:** 31 May 2018

**Published:** 20 June 2018

**Citation:**

Cagliero J, Villanueva SYAM and
Matsui M (2018) Leptospirosis
Pathophysiology: Into the Storm of
Cytokines.

Front. Cell. Infect. Microbiol. 8:204.
doi: 10.3389/fcimb.2018.00204

## INTRODUCTION

Leptospirosis is a re-emerging neglected zoonosis, caused by pathogenic spirochete bacteria from the genus *Leptospira* and estimated to infect more than a million people with approximately 60,000 deaths annually (Costa et al., 2015a,b; Picardeau, 2015). Number of fatal cases is comparable to or even higher than some other important neglected tropical diseases such as severe dengue or visceral leishmaniasis (Picardeau, 2015). Leptospirosis occurs after direct or indirect contact with bacteria shed in the urine of reservoir animals, mostly rodents, in which infection is asymptomatic and results in chronic renal carriage (Adler and de la Pena Moctezuma, 2010). Clinical manifestations in infected humans are extremely variable, including flu-like symptoms, and spontaneously resolve in 90% of cases (Haake and Levett, 2015; Gomes-Solecki et al., 2017). However, 10% of patients develop severe forms of the disease and are designated as susceptible hosts in this review. Severe human leptospirosis is characterized by multi-organ failures and is associated with a dramatic increase in the mortality rate (Adler and de la Pena Moctezuma, 2010; Haake and Levett, 2015).
Hepatic dysfunctions associated with renal failure and hemorrhages constitute Weil's syndrome, a severe form of leptospirosis (Haake and Levett, 2015). Acute kidney injury (AKI) is commonly reported as an early manifestation of acute leptospirosis and could possibly evolve to chronic kidney disease (CKD) (Correa-Rotter et al., 2014; Herath et al., 2014). Severe pulmonary hemorrhagic syndrome (SPHS) with acute respiratory distress syndrome (ARDS) can also occur and can be confused with viral pneumonitis (Trevejo et al., 1998; Haake and Levett, 2015).

Although it is still unclear why leptospirosis patients present with various clinical manifestations, both innate and adaptive immune responses to *Leptospira* infection influence the outcome of the disease. Induction of an inflammatory response due to an infection with a pathogen can initiate destructive immune mechanisms leading to host tissue damages, sepsis and death. Interestingly, the cytokine storm process was suggested to have a role in the development of severe leptospirosis, especially in humans (Reis et al., 2013; Haake and Levett, 2015). In this review, we summarized evidences supporting this hypothesis, mainly based on results from studies on hosts susceptible and resistant to lethal infection.

## INFLAMMATORY RESPONSE TO LEPTOSPIRA INFECTION

During an infection, contact with pathogens activates the innate immune system by generating an inflammatory response. Microbial Pathogen-Associated Molecular Patterns (PAMPs) will be recognized by the Pattern Recognition Receptors (PRRs) expressed at the surface of innate immune cells, mainly the Toll-like receptors (TLRs) and nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) (Akira et al., 2006). The PAMPs/PRR association triggers an inflammatory cascade by activating multiple intracellular signaling pathways, including the NF-κB and activator protein 1 (AP-1) transcription factors (Schroder and Tschopp, 2010), which in turn regulate the expression of cytokines, Prostaglandins (PGs), and Nitric Oxide (NO) (Tisoncik et al., 2012; Turner et al., 2014). PGs and NO are pro-inflammatory molecules that increase arterial dilation and vascular permeability, both being key events required for the influx of immune cells (Ricciotti and FitzGerald, 2011; Wink et al., 2011). Pro-inflammatory cytokines include interleukins (IL)-1β, IL-6, IL-12, interferons (IFNs) and tumor necrosis factors (TNFs), as well as chemokines, which act as chemoattractants to recruit leucocytes to the site of tissue damage and/or infection (Tisoncik et al., 2012; Turner et al., 2014). Interestingly, AP-1 and NF-κB also modulate the pro-inflammatory response through the induction of immunomodulatory cytokines as IL-4, IL-10, IL-13 or Transforming Growth Factor-β (TGF-β) acting in concert with cytokines inhibitors to offset the massive induction of pro-inflammatory mediators (Dinarello, 2007; Turner et al., 2014).

Data show that leptospiral PAMPs stimulate innate immunity through several PRRs to produce cytokines and activate the inflammatory cascade, as was recently reviewed by C. Werts

(Werts, 2017). Mechanisms underlying the specific leptospiral PAMPs/PRR-triggered inflammation have not yet been fully elucidated. Interestingly, in contrast to other bacterial LPS (e.g., from *E. coli*) that classically activates TLR4 signaling pathway, leptospiral LPS is not recognized by TLR4, but by TLR2 in human cells, while both TLR2 and TLR4 are activated in mice (Nahori et al., 2005). Moreover, TLR4-deficient mice develop clinical signs of severe leptospirosis (Gomes-Solecki et al., 2017), which show that murine TLR4 protect mice from developing leptospirosis. This species specificity in leptospiral PAMPs sensing also suggest that hosts could trigger different inflammatory responses according to their susceptibility to leptospirosis.

## CYTOKINE STORM IN SEVERE LEPTOSPIROSIS

Inflammatory cytokines and cytokine regulators interact in a complex network finely controlled to clear the pathogens without excessive inflammation-induced organ damage. Indeed, severe infectious diseases are often associated with a prolonged increase in pro-inflammatory IL-1β, TNF-α, IL-6 expression, or “cytokine storm,” causing persistent inflammation and followed by a massive and systemic production of anti-inflammatory cytokines, causing a state of “immunoparalysis” (Tisoncik et al., 2012; Zhao et al., 2015). Consequently, tissue edema impairs local organ perfusion, which can result in loss of organ function; furthermore, prolonged endothelial permeabilization can lead to pathogen invasion into the bloodstream and result in a sepsis-like syndrome (Cohen, 2002; Tisoncik et al., 2012). In fact sepsis is now defined as a life-threatening organ dysfunction caused by a dysregulated host response to an infection (Singer et al., 2016) and is referred to as a “cytokine storm-induced syndrome” (Chousterman et al., 2017).

Clinical signs of severe leptospirosis in susceptible hosts include increased leptospiremia and multi-organ failure, specifically affecting kidneys, liver and lungs (Levett, 2001; Haake and Levett, 2015; Yilmaz et al., 2015). Interestingly, these clinical features meet the criterions for a sepsis diagnosis, which suggest that development of severe leptospirosis could be associated with a dysregulated inflammation. Interestingly, data obtained from clinical studies support this hypothesis. The very first quantifications of cytokines in human leptospirosis showed significant increase in TNF-α level from patient sera (Estavoyer et al., 1991; Tajiki and Salomão, 1996; Tajiki et al., 1997). Further investigations reported higher production of cytokines in severe compared to mild disease (Reis et al., 2013; Mikulski et al., 2015; Chirathaworn et al., 2016). Serum levels of pro-inflammatory IL-6, chemokine IL-8 and anti-inflammatory IL-10 were significantly higher among patients that developed SPHS compared to non-SPHS leptospirosis patients (Reis et al., 2013). In addition, concentrations of these cytokines were elevated in sera from patients with organ dysfunction compared to mild cases without organ involvement (Chirathaworn et al., 2016). Experimental infection also showed evidence of differential pattern of cytokine expression depending on resistance or susceptibility of animal models (Figure 1). Strictly regulated
induction of pro-inflammatory cytokines IL-1β, IL-6, TNF-α and chemokines CXCL10/IP-10 and CCL3/MIP-1α in resistant mice contrasted with delayed and massive overexpression in susceptible hamsters developing severe tissue lesions (Matsui et al., 2011). Overexpression of anti-inflammatory IL-10 was faster and at higher levels in resistant mice than in hamsters (Matsui et al., 2017). Moreover, expression of TNF-α, IL-1α, and IL-10 were significantly higher in lethally infected hamsters compared to survivors (Kernel-Pauillac and Goarant, 2010). Based on these, dramatic imbalance in the cytokine production upon *Leptospira* infection might play a considerable role in the development of severe leptospirosis.

# ROLE OF CYTOKINES IN THE PATHOPHYSIOLOGY OF SEVERE LEPTOSPIROSIS

## Pro-inflammatory Cytokines

Although TNF-α was the first cytokine to be associated with leptospirosis severity (Estavoyer et al., 1991; Tajiki and Salomão, 1996), its precise role in the disease pathophysiology is still under debate. Macrophage apoptosis induced by *L. interrogans* *in vitro* is triggered via caspase-8 and caspase-3-dependent pathways (Jin et al., 2009), and *Leptospira* were suggested to induce apoptosis in organs though the caspase-3-dependent pathway in infected mice (Marinho et al., 2015). Thus, TNF-α might play a role in *Leptospira*-induced apoptosis as it can activate caspase-3- and caspase-8-associated apoptosis (Zhao et al., 2001; Wang et al., 2008).

Kyriakidis et al. reported that TNF-α was the only cytokine found associated with SHPS in leptospirosis patients (Kyriakidis et al., 2011). Alteration of sodium channel was suggested as a cause for the pulmonary damages observed in susceptible *Leptospira*-infected hamsters (Andrade et al., 2007). Interestingly, TNF-α, together with IL-1β, regulate the expression of sodium channel sub-units *in vitro*, which could be part of pulmonary damages underlying mechanism (Yamagata et al., 2009).

Pro-inflammatory IL-6 is induced by TNF-α and IL-1β and produced by a large number of immune and non-immune cells. High concentration of IL-6 is an indicator of septic shock and correlates to leptospirosis severity and SPHS (Reis et al., 2013; Schulte et al., 2013; Papa and Kotrotsiou, 2015). As TNF-α and IL-1β, IL-6 can also activate the coagulation system, especially in endotoxemic models (Schulte et al., 2013). This could relate to clinical bleedings, especially in SHPS (Haake and Levett, 2015), and activation of coagulation (Wagenaar et al., 2010) observed in severe leptospirosis.

High levels of chemokines are found in susceptible hamsters (Matsui et al., 2016), and are associated with organ damage and poor outcome (Reis et al., 2013; Papa and Kotrotsiou, 2015). Notably, higher level of CXCL8/IL-8 expression was found in patients with severe clinical signs and was associated with mortality (Wagenaar et al., 2009a,b). Moreover, high levels of adhesion molecules, ICAM-1 or VCAM, are also associated with leptospirosis-induced organ damages (Del Carlo Bernardi et al., 2012). Chemokines along with endothelial adhesion molecules

are induced by TNF-α, which promotes leukocytes attraction and extravasation into injured tissue. Their prolonged production can also promote endothelial barrier disruption and diapedesis, which could explain hemorrhages and immune cells infiltrations in tissues associated with severe leptospirosis.

Together with IL-1β, TNF-α promote the activation of immune cells as macrophages, and subsequent secretion of immuno-regulators including pro-inflammatory factors that amplify the inflammatory response. Moreover, high TNF-α and IL-1 circulating levels are considered as the hallmarks of a cytokine storm and their role in sepsis pathophysiology has been largely investigated (Schulte et al., 2013). These data place TNF-α and IL-1β as master conductors of the awry inflammatory response and the subsequent cytokine storm-induced sepsis observed in severe leptospirosis. However, it also emphasizes that these cytokines may not be the best candidates for investigating specific immune responses to a *Leptospira* infection and for selection of biomarkers for severity prognosis. Genetic studies showing no correlation between TNF-α polymorphisms and leptospirosis outcome are in good accordance with this hypothesis (Lingappa et al., 2004).

## Anti-inflammatory and Immunomodulatory Cytokines

Following the onset of a cytokine storm, systemic production of IL-10 is considered as a hallmark of an attempt to restore immunological homeostasis (Tisoncik et al., 2012). High level of IL-10 in septic patients significantly correlates with sepsis and death suggesting profound immunosuppression (Gogos et al., 2000). It also influences the clearance of microorganisms in the host (Duell et al., 2012). In Lyme borreliosis, a disease due to an infection by another spirochete, *Borrelia burgdorferi*, contribution of IL-10 in the attenuation of tissue lesions was shown through the modulation of pro-inflammatory cytokines (Brown et al., 1999; Gautam et al., 2011). Inhibition of endogenous IL-10 also enhanced *Borrelia* elimination (Brown et al., 1999).

In human leptospirosis, controversial results showed either higher levels of IL-10 (Reis et al., 2013; Chirathaworn et al., 2016) or no significant difference in IL-10 levels (Wagenaar et al., 2009a; Mikulski et al., 2015) between mild and severe forms. However, asymptomatic leptospirosis presented an anti-inflammatory response with higher IL-10-producing CD4+ T-cells compared to patients with severe or mild leptospirosis (Volz et al., 2015). Differences in time of sampling might explain this discrepancy. Interestingly, in a murine Cecal Ligation and Puncture (CLP)-induced sepsis model, the inhibition of IL-10 at the time of CLP worsened mortality rate whereas it increased survival when administered 12 h later (Song et al., 1999). Thus, IL-10 contribution in leptospirosis pathophysiology probably depends on the stage and severity of the disease. Altogether, these findings suggest that IL-10 could either be protective by counterbalancing pro-inflammatory cytokines during the early stage of the disease, or have harmful effect in the leptospirosis outcome acting on bacterial burden. Finally, genetic variations could also contribute to the IL-10 dual role since IL-10 promoter
<figure><img src="image_3.png" /></figure>

polymorphisms were associated with lower LPS-dependent IL-10 production and with the development of sepsis in patients with major trauma (Zeng et al., 2009).

Inflammatory response is also restricted by regulatory cytokines, as IL-4 or IL-13, promoting T helper (Th) lymphocyte differentiation toward Th2 lineage, suppressing tissue-damaging effects of sustained inflammation (Opal and Depalo, 2000). Moreover, aberrant production of these cytokines facilitates pathogen invasion during infection (Wynn, 2015). IL-4 is induced during leptospirosis with late but massive overexpression in blood from experimentally infected hamsters (Vernel-Pauillac and Merien, 2006). Serum levels of IL-4 were also increased in human patients (Reis et al., 2013) and

frequencies in IL-4 and IL-4R receptor gene polymorphisms were significantly higher in leptospirosis patients compared to healthy subjects (Fialho et al., 2009). Similarly to IL-10, the role of IL-4 in sepsis is still under debate (Chousterman et al., 2017)

Thus, induction of IL-4 and IL-10 might play an important role in leptospirosis pathophysiology that still needs to be precisely described. Indeed, these cytokines could relate to impaired bacterial clearance by restricting pro-inflammatory responses and consequently triggering immunoparalysis related to fulminant septicemia in human leptospirosis (Tisoncik et al., 2012; Zhao et al., 2015).
# RESISTANT PHENOTYPE TO LEPTOSPIRA INFECTION: ROLE OF THE IMMUNE RESPONSE

Although hamsters and guinea pigs are suitable models to study acute leptospirosis, the cost of their handling and the lack of experimental tools have limited their use in laboratories. As mentioned above, mice, which are much easier to handle, are resistant to *Leptospira* infection and become chronic carrier of the bacterium. However, variable degrees of susceptibility have been observed using different mice strains, which allowed scientists to consider mice as suitable models for studying severe leptospirosis. Consequently, a large number of transgenic, mutant, or immunosuppressed mice are now being used as models of chronic, sub-lethal and lethal leptospirosis (see Gomes-Solecki et al., 2017 for review).

Contrasting with delayed and uncontrolled cytokine production observed in susceptible hosts, the inflammatory response in resistant models is characterized by an early but tightly regulated induction of pro-inflammatory cytokines, and a fast and high overexpression of the anti-inflammatory IL-10 (Figure 1). Recently, higher chemokines levels including CCL5/RANTES and CCL8/MCP-2 were quantified in organs from resistant (BALB/c) compared to susceptible (TLR4-defective C3H/HeJ) mice 24 h post-infection (Domingos et al., 2017). Moreover, high expression of chemokines CXCL1/KC, CXCL2/MIP-2, CCL5/RANTES, as well as IL-1β, TNF-α, and IL-10 was observed in sub-lethally infected C3H/HeJ mice (Richer et al., 2015; Sullivan et al., 2017). This phenotype specificity in the immune response is supported by previous data showing that expression of TNF-α and of CXCL2/MIP-2 chemokine is delayed in organs from susceptible mice (da Silva et al., 2012). Thus, time of induction of chemokines and key cytokines seems to be determinant for the development of a resistant phenotype to *Leptospira* infection.

Moreover, and supporting the possible dual role of IL-10, recent studies reported improved bacterial clearance in mouse kidneys in the absence of IL-10 compared to control animals (Devlin et al., 2017; Matsui et al., 2017). Interestingly, IL-10 deficiency did not affect *Leptospira*-dependent induction of TNF-α and IL-6 while it enhanced IL-1β and IFN-γ overexpression. Thus, IL-10 might inhibit the effective clearance of *Leptospira* through the early regulation of particular inflammatory cytokines, leading to the persistence of bacteria and allowing chronic carriage in kidneys of resistant animals. It is noteworthy that no clinical signs were observed in *Leptospira*-infected $Il-10^{-/−}$ mice (Devlin et al., 2017) while IL-10 neutralization led to weight loss in infected OF1 mice (Matsui et al., 2017).

Finally, expression of the anti-inflammatory TGF-β is not modified in the blood (Vernel-Pauillac and Goarant, 2010; Fujita et al., 2015) while induced in the kidneys (Lowanitchapat et al., 2010) from *Leptospira*-infected hamsters during the acute stage of the disease. Interestingly, renal TGF-β1 expression is downregulated in asymptomatic mice during chronic carriage of *Leptospira* (Matsui et al., 2016) contrasting with unchanged

expression level in fibrotic kidneys from susceptible mice compared to control (Fanton d'Andon et al., 2014; Ferrer et al., 2014). Consistently with the pro-fibrotic role of this cytokine in renal fibrogenesis (Higgins et al., 2018), and beyond its anti-inflammatory effect, this cytokine might specifically participate in renal pathophysiology of leptospirosis.

# DISCUSSION

Inflammation is essential for the resolution of microbial infections and involves complex processes that finely coordinate cytokine production. Dysregulation of these mechanisms can trigger cytokine storm and related multi-organ failures as observed during severe leptospirosis and sepsis. Interestingly, the Jarisch-Herxheimer Reaction (JHR) noticed among leptospirosis patients is also characterized by large cytokine overproduction induced by massive bacterial product release consequent to antibiotic treatment (Friedland and Warrell, 1991; Guerrier and D'ortenzio, 2013; Guerrier et al., 2017). It is worth noticing that anti-TNF-α antibody therapy was proposed to prevent and ameliorate the JHR (Pound and May, 2005; Butler, 2017). However, despite the well-established involvement of cytokines in sepsis as observed in severe leptospirosis, no efficient treatment targeting inflammation was clinically validated. Indeed, data obtained from calibrated pre-clinical models can barely be translated to human diseases (van der Worp et al., 2010; McCarron et al., 2015). Thus, improving knowledge of the host innate immunity in leptospirosis is a major challenge to ameliorate therapeutic approaches, especially in severe forms of leptospirosis that are associated with a dramatic increase in mortality rate.

During *Leptospira* infection, inflammatory mediators are rapidly regulated in resistant models contrasting with awry production in susceptible hosts, and cytokines were thus proposed as promising biomarkers of the disease outcome in several clinical studies. However, larger and multi-factorial investigations are still required, including cytokine kinetics critical over the course of infection. Unfortunately, in patients, precise time of infection and infecting dose are hardly determined. Moreover, mediators are usually quantified in sera, but specific profiling of host response, including the identification of cellular sources for their production, in altered tissues would necessarily improve our understanding of inflammatory dysfunctions in organs.

Management of severe leptospirosis is also complex due to the diversity of clinical symptoms and immunological profiles found among patients. Human genetic background should be taken into consideration as highlighted by susceptible TLR4 deficient C3H/HeJ mice. However, only a few studies have investigated the correlation between genetic variability and leptospirosis severity and results are still under debate (Fialho et al., 2009; Esteves et al., 2014; Cedola et al., 2015). Finally, pathogen virulence will inevitably influence the host immune response. Several leptospiral components were described as virulence factors, including genes implicated in motility and LPS synthesis, but also genes whose functions still remain undescribed.
## AUTHOR CONTRIBUTIONS

MM drafted the review. JC, SV, and MM contributed to the writing process.

## FUNDING

The research position of MM and JC are financed by the Government of New Caledonia. This program is co-funded by

the French Ministry of Research and Technology, Institut Pasteur de Nouvelle-Calédonie, and Institut Pasteur de Paris.

## ACKNOWLEDGMENTS

The French Ministry of Research and Technology, Institut Pasteur in New Caledonia, and Institut Pasteur in Paris supported this work. Positions of MM and JC are financed by the Government of New Caledonia.

## REFERENCES

* Adler, B., and de la Pena Moctezuma, A. (2010). *Leptospira* and leptospirosis. *Vet. Microbiol.* **140**, 287–296. doi: 10.1016/j.vetmic.2009.03.012

* Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innate immunity. *Cell* **124**, 783–801. doi: 10.1016/j.cell.2006.02.015

* Andrade, L., Rodrigues, A. C. Jr., Sanches, T. R., Souza, R. B., and Seguro, A. C. (2007). Leptospirosis leads to dysregulation of sodium transporters in the kidney and lung. *Am. J. Physiol. Renal Physiol.* **292**, F586–F592. doi: 10.1152/ajprenal.00102.2006

* Brown, J. P., Zachary, J. F., Teuscher, C., Weis, J. J., and Wooten, R. M. (1999). Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. *Infect. Immun.* **67**, 5142–5150.

* Butler, T. (2017). The jarisch-herxheimer reaction after antibiotic treatment of spirochetal infections: a review of recent cases and our understanding of pathogenesis. *Am. J. Trop. Med. Hyg.* **96**, 46–52. doi: 10.4269/ajtmh.16-0434

* Cedola, M., Chiani, Y., Pretre, G., Alberdi, L., Vanasco, B., and Gomez, R. M. (2015). Association of toll-like receptor 2 Arg753Gln and toll-like receptor 1 Ile602Ser single-nucleotide polymorphisms with leptospirosis in an argentine population. *Acta Trop.* **46**, 73–80. doi: 10.1016/j.acatropica.2015.03.007

* Chirathaworn, C., Supputtamongkol, Y., Lertmaharit, S., and Poovorawan, Y. (2016). Cytokine levels as biomarkers for leptospirosis patients. *Cytokine* **85**, 80–82. doi: 10.1016/j.cyto.2016.06.007

* Chousterman, B. G., Swirski, F. K., and Weber, G. F. (2017). Cytokine storm and sepsis disease pathogenesis. *Semin. Immunopathol.* **39**, 517–528. doi: 10.1007/s00281-017-0639-8

* Cohen, J. (2002). The immunopathogenesis of sepsis. *Nature* **420**, 885–891. doi: 10.1038/nature01326

* Correa-Rotter, R., Wesseling, C., and Johnson, R. J. (2014). CKD of unknown origin in Central America: the case for a Mesoamerican nephropathy. *Am. J. Kidney Dis.* **63**, 506–520. doi: 10.1053/j.ajkd.2013.10.062

* Costa, F., Hagan, J. E., Calcagno, J., Kane, M., Torgerson, P., Martinez-Silveira, M. S., et al. (2015a). Global morbidity and mortality of leptospirosis: a systematic review. *PLoS Negl. Trop. Dis.* **9**:e0003898. doi: 10.1371/journal.pntd.0003898

* Costa, F., Wunder, E. A. Jr., De Oliveira, D., Bisht, V., Rodrigues, G., Reis, M. G., et al. (2015b). Patterns in *Leptospira* shedding in norway rats (*Rattus norvegicus*) from Brazilian slum communities at high risk of disease transmission. *PLoS Negl. Trop. Dis.* **9**:e0003819. doi: 10.1371/journal.pntd.0003819

* da Silva, J. B., Carvalho, E., Covarrubias, A. E., Ching, A. T., Mattaraia, V. G., Paiva, D., et al. (2012). Induction of TNF-alfa and CXCL-2 mRNAs in different organs of mice infected with pathogenic *Leptospira*. *Microb. Pathog.* **52**, 206–216. doi: 10.1016/j.micpath.2012.01.002

* Del Carlo Bernardi, F., Ctenas, B., Da Silva, L. F., Nicodemo, A. C., Saldiva, P. H., Dolhnikoff, M., et al. (2012). Immune receptors and adhesion molecules in human pulmonary leptospirosis. *Hum. Pathol.* **43**, 1601–1610. doi: 10.1016/j.humpath.2011.11.017

* Devlin, A. A., Halvorsen, P. J., Miller, J. C., and Laster, S. M. (2017). Il-10 deficient mice express IFN-gamma mRNA and clear *Leptospira interrogans* from their kidneys more rapidly than normal C57BL/6 mice. *Immunobiology* **222**, 768–777. doi: 10.1016/j.imbio.2017.02.004

* Dinarello, C. A. (2007). Historical review of cytokines. *Eur. J. Immunol.* **37**(Suppl. 1), S34–S45. doi: 10.1002/eji.200737772

* Domingos, R. H., Pavanel, E. B., Nakajima, E., Schons-Fonseca, L., Da Costa, R. M. A., De Franco, M., et al. (2017). Resistance of mice to *Leptospira* infection and correlation with chemokine response. *Immunobiology* **222**, 1004–1013. doi: 10.1016/j.imbio.2017.05.017

* Duell, B. L., Tan, C. K., Carey, A. J., Wu, F., Cripps, A. W., and Ulett, G. C. (2012). Recent insights into microbial triggers of interleukin-10 production in the host and the impact on infectious disease pathogenesis. *FEMS Immunol. Med. Microbiol.* **64**, 295–313. doi: 10.1111/j.1574-695X.2012.00931.x

* Estavoyer, J. M., Racadot, E., Couetdic, G., Leroy, J., and Grosperrin, L. (1991). Tumor necrosis factor in patients with leptospirosis. *Rev. Infect. Dis.* **13**, 1245–1246. doi: 10.1093/clinids/13.6.1245

* Esteves, L. M., Bulhões, S. M., Branco, C. C., Mota, F. M., Paiva, C., Cabral, R., et al. (2014). Human leptospirosis: seroreactivity and genetic susceptibility in the population of Sao Miguel Island (Azores, Portugal). *PLoS ONE* **9**:e108534. doi: 10.1371/journal.pone.0108534

* Fanton d'Andon, M., Quellard, N., Fernandez, B., Ratet, G., Lacroix-Lamandé, S., Vandewalle, A., et al. (2014). *Leptospira interrogans* induces fibrosis in the mouse kidney through Inos-dependent, TLR- and NLR-independent signaling pathways. *PLoS Negl. Trop. Dis.* **8**:e2664. doi: 10.1371/journal.pntd.0002664

* Ferrer, M. F., Scharrig, E., Alberdi, L., Cedola, M., Pretre, G., Drut, R., et al. (2014). Decay-accelerating factor 1 deficiency exacerbates leptospiiral-induced murine chronic nephritis and renal fibrosis. *PLoS ONE* **9**:e102860. doi: 10.1371/journal.pone.0102860

* Fialho, R. N., Martins, L., Pinheiro, J. P., Bettencourt, B. F., Couto, A. R., Santos, M. R., et al. (2009). Role of HLA, KIR and cytokine gene polymorphisms in leptospirosis. *Hum. Immunol.* **70**, 915–920. doi: 10.1016/j.humimm.2009.08.007

* Friedland, J. S., and Warrell, D. A. (1991). The Jarisch-herxheimer reaction in leptospirosis: possible pathogenesis and review. *Rev. Infect. Dis.* **13**, 207–210. doi: 10.1093/clinids/13.2.207

* Fujita, R., Koizumi, N., Sugiyama, H., Tomizawa, R., Sato, R., and Ohnishi, M. (2015). Comparison of bacterial burden and cytokine gene expression in golden hamsters in early phase of infection with two different strains of *Leptospira interrogans*. *PLoS ONE* **10**:e0132694. doi: 10.1371/journal.pone.0132694

* Gautam, A., Dixit, S., Philipp, M. T., Singh, S. R., Morici, L. A., Kaushal, D., et al. (2011). Interleukin-10 alters effector functions of multiple genes induced by *Borrelia burgdorferi* in macrophages to regulate Lyme disease inflammation. *Infect. Immun.* **79**, 4876–4892. doi: 10.1128/IAI.05415-11

* Gogos, C. A., Drosou, E., Bassaris, H. P., and Skoutelis, A. (2000). Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. *J. Infect. Dis.* **181**, 176–180. doi: 10.1086/315214

* Gomes-Solecki, M., Santeccchia, I., and Werts, C. (2017). Animal models of leptospirosis: of Mice and Hamsters. *Front. Immunol.* **8**:58. doi: 10.3389/fimmu.2017.00058

* Guerrier, G., and D'ortenzio, E. (2013). The jarisch-herxheimer reaction in leptospirosis: a systematic review. *PLoS ONE* **8**:e59266. doi: 10.1371/journal.pone.0059266

* Guerrier, G., Lefèvre, P., Chouvin, C., and D'ortenzio, E. (2017). Jarisch-herxheimer reaction among patients with leptospirosis: incidence and risk factors. *Am. J. Trop. Med. Hyg.* **96**, 791–794. doi: 10.4269/ajtmh.16-0457
Haake, D. A., and Levett, P. N. (2015). Leptospirosis in humans. *Curr. Top. Microbiol. Immunol.* 387, 65–97. doi: 10.1007/978-3-662-45059-8_5

Herath, N. J., Kularatne, S. A., Weerakoon, K. G., Wazil, A., Subasinghe, N., and Ratnatunga, N. V. (2014). Long term outcome of acute kidney injury due to leptospirosis? A longitudinal study in Sri Lanka. *BMC Res. Notes* 7:398. doi: 10.1186/1756-0500-7-398

Higgins, S. P., Tang, Y., Higgins, C. E., Mian, B., Zhang, W., Czekay, R. P., et al. (2018). TGF-beta1/p53 signaling in renal fibrogenesis. *Cell Signal* 31, 1–10. doi: 10.1016/j cellsig.2017.11.005

Jin, D., Ojcius, D. M., Sun, D., Dong, H., Luo, Y., Mao, Y., et al. (2009). *Leptospira interrogans* induces apoptosis in macrophages via caspase-8 and caspase-3-dependent pathways. *Infect. Immun.* 77, 799–809. doi: 10.1128/IAI.00914-08

Kyriakidis, I., Samara, P., and Papa, A. (2011). Serum TNF-alpha, sTNFR1, IL-6, IL-8 and IL-10 levels in Weil's syndrome. *Cytokine* 54, 117–120. doi: 10.1016/j.cyto.2011.01.014

Levett, P. N. (2001). Leptospirosis. *Clin. Microbiol. Rev.* 14, 296–326. doi: 10.1128/CMR.14.2.296-326.2001

Lingappa, J., Kuffner, T., Tappero, J., Whitworth, W., Mize, A., Kaiser, R., et al. (2004). HLA-DQ6 and ingestion of contaminated water: possible gene-environment interaction in an outbreak of Leptospirosis. *Genes Immun.* 5, 197–202. doi: 10.1038/sj.gene.6364058

Lowanitchapat, A., Payungporn, S., Seereemaspun, A., Ekpo, P., Phulsuksombati, D., Poovorawan, Y., et al. (2010). Expression of TNF-alpha, TGF-beta, IP-10 and IL-10 mRNA in kidneys of hamsters infected with pathogenic *Leptospira*. *Comp. Immunol. Microbiol. Infect. Dis.* 33, 423–434. doi: 10.1016/j.cimid.2009.05.001

Marinho, M., Taparo, C. V., Oliveira-Junior, I. S., Perri, S. H., and Cardoso, T. C. (2015). Tissue apoptosis in mice infected with *Leptospira interrogans* serovar Icterohaemorrhagiae. *J. Venom. Anim. Toxins Incl. Trop. Dis.* 21:22. doi: 10.1186/s40409-015-0022-y

Matsui, M., Roche, L., Geroult, S., Soupe-Gilbert, M. E., Monchy, D., Huerre, M., et al. (2016). Cytokine and chemokine expression in kidneys during chronic leptospirosis in reservoir and susceptible animal models. *PLoS ONE* 11:e0156084. doi: 10.1371/journal.pone.0156084

Matsui, M., Roche, L., Soupé-Gilbert, M.-E., Hasan, M., Monchy, D., and Goarant, C. (2017). High level of IL-10 expression in the blood of animal models possibly relates to resistance against leptospirosis. *Cytokine* 96, 144–151. doi: 10.1016/j.cyto.2017.03.009

Matsui, M., Rouleau, V., Bruyere-Ostells, L., and Goarant, C. (2011). Gene expression profiles of immune mediators and histopathological findings in animal models of leptospirosis: comparison between susceptible hamsters and resistant mice. *Infect. Immun.* 79, 4480–4492. doi: 10.1128/IAI.05727-11

McCarron, E. P., Williams, D. P., Antoine, D. J., Kipar, A., Lemm, J., Stehr, S., et al. (2015). Exploring the translational disconnect between the murine and human inflammatory response: analysis of LPS dose-response relationship in murine versus human cell lines and implications for translation into murine models of sepsis. *J. Inflamm. Res.* 8, 201–209. doi: 10.2147/JIR.S89097

Mikulski, M., Boisier, P., Lacassin, F., Soupe-Gilbert, M. E., Mauron, C., Bruyere-Ostells, L., et al. (2015). Severity markers in severe leptospirosis: a cohort study. *Eur. J. Clin. Microbiol. Infect. Dis.* 34, 687–695. doi: 10.1007/s10096-014-2275-8

Nahori, M. A., Fournie-Amazouz, E., Que-Gewirth, N. S., Balloy, V., Chignard, M., Raetz, C. R., et al. (2005). Differential TLR recognition of leptospiral lipid A and lipopolysaccharide in murine and human cells. *J. Immunol.* 175, 6022–6031. doi: 10.4049/jimmunol.175.9.6022

Opal, S. M., and Depalo, V. A. (2000). Anti-inflammatory cytokines. *Chest* 117, 1162–1172. doi: 10.1378/chest.117.4.1162

Papa, A., and Kotrotsiou, T. (2015). Cytokines in human leptospirosis. *Trans. R. Soc. Trop. Med. Hyg.* 109, 749–754. doi: 10.1093/trstmh/trv095

Picardeau, M. (2015). Leptospirosis: updating the global picture of an emerging neglected disease. *PLoS Negl. Trop. Dis.* 9:e0004039. doi: 10.1371/journal.pntd.0004039

Pound, M. W., and May, D. B. (2005). Proposed mechanisms and preventative options of Jarisch-Herxheimer reactions. *J. Clin. Pharm. Ther.* 30, 291–295. doi: 10.1111/j.1365-2710.2005.00631.x

Reis, E. A., Hagan, J. E., Ribeiro, G. S., Teixeira-Carvalho, A., Martins-Filho, O. A., Montgomery, R. R., et al. (2013). Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis. *PLoS Negl. Trop. Dis.* 7:e2457. doi: 10.1371/journal.pntd.0002457

Ricciotti, E., and FitzGerald, G. A. (2011). Prostaglandins and inflammation. *Arterioscler. Thromb. Vasc. Biol.* 31, 986–1000. doi: 10.1161/ATVBAHA. 110.207449

Richer, L., Potula, H. H., Melo, R., Vieira, A., and Gomes-Solecki, M. (2015). Mouse model for sublethal *Leptospira interrogans* infection. *Infect. Immun.* 83, 4693–4700. doi: 10.1128/IAI.01115-15

Schroder, K., and Tschopp, J. (2010). The inflammasomes. *Cell* 140, 821–832. doi: 10.1016/j.cell.2010.01.040

Schulte, W., Bernhagen, J., and Bucala, R. (2013). Cytokines in sepsis: potent immunoregulators and potential therapeutic targets–an updated view. *Mediators Inflamm.* 2013:165974. doi: 10.1155/2013/165974

Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., et al. (2016). The third international consensus definitions for sepsis and septic shock (Sepsis-3). *JAMA* 315, 801–810. doi: 10.1001/jama.2016.0287

Song, G. Y., Chung, C. S., Chaudry, I. H., and Ayala, A. (1999). What is the role of interleukin 10 in polymicrobial sepsis: anti-inflammatory agent or immunosuppressant? *Surgery* 126, 378–383. doi: 10.1016/S0039-6060(99)70180-7

Sullivan, J. P., Nair, N., Potula, H. H., and Gomes-Solecki, M. (2017). Eye-drop inoculation leads to sublethal leptospirosis in mice. *Infect. Immun.* 85:e01050-16. doi: 10.1128/IAI.01050-16

Tajiki, M. H., Nakama, A. S. Y., and Salomão, R. (1997). The ratio of plasma levels Of Il-10/Tnf-alpha and its relationship to disease severity and survival in patients with leptospirosis. *Braz. J. Infect. Dis.* 1, 138–141.

Tajiki, M. H., and Salomão, R. (1996). Association of plasma levels of Tumour Necrosis Factor α with severity of disease and mortality among patients with leptospirosis. *Clin. Infect. Dis.* 23, 1177–1178. doi: 10.1093/clinids/23.5.1177

Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., and Katze, M. G. (2012). Into the eye of the cytokine storm. *Microbiol. Mol. Biol. Rev.* 76, 16–32. doi: 10.1128/MMBR.05015-11

Trevejo, R. T., Rigau-Perez, J. G., Ashford, D. A., Mcclure, E. M., Jarquin-Gonzalez, C., Amador, J. J., et al. (1998). Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua 1995. *J. Infect. Dis.* 178, 1457–1463. doi: 10.1086/314424

Turner, M. D., Nedjai, B., Hurst, T., and Pennington, D. J. (2014). Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. *Biochim. Biophys. Acta* 1843, 2563–2582. doi: 10.1016/j.bbamcr.2014. 05.014

van der Worp, H. B., Howells, D. W., Sena, E. S., Porritt, M. J., Rewell, S., O'Collins, V., et al. (2010). Can animal models of disease reliably inform human studies? *PLoS Med.* 7:e1000245. doi: 10.1371/journal.pmed.1000245

Vernel-Pauillac, F., and Goarant, C. (2010). Differential cytokine gene expression according to outcome in a hamster model of leptospirosis. *PLoS Negl. Trop. Dis.* 4:e582. doi: 10.1371/journal.pntd.0000582

Vernel-Pauillac, F., and Merien, F. (2006). Proinflammatory and immunomodulatory cytokine mRNA time course profiles in hamsters infected with a virulent variant of *Leptospira interrogans*. *Infect. Immun.* 74, 4172–4179. doi: 10.1128/IAI.00447-06

Volz, M. S., Moos, V., Allers, K., Luge, E., Mayer-Scholl, A., Nockler, K., et al. (2015). Specific CD4+ T-cell reactivity and cytokine release in different clinical presentations of leptospirosis. *Clin. Vaccine Immunol.* 22, 1276–1284. doi: 10.1128/CVI.00397-15

Wagenaar, J. F., Gasem, M. H., Goris, M. G., Leeflang, M., Hartskeerl, R. A., Van Der Poll, T., et al. (2009a). Soluble ST2 levels are associated with bleeding in patients with severe leptospirosis. *PLoS Negl. Trop. Dis.* 3:e453. doi: 10.1371/journal.pntd.0000453

Wagenaar, J. F., Goris, M. G., Gasem, M. H., Isbandrio, B., Moalli, F., Mantovani, A., et al. (2009b). Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis. *J. Infect.* 58, 425–432. doi: 10.1016/j.jinf.2009.04.004

Wagenaar, J. F., Goris, M. G., Partiningrum, D. L., Isbandrio, B., Hartskeerl, R. A., Brandjes, D. P., et al. (2010). Coagulation disorders in patients with severe leptospirosis are associated with severe bleeding and mortality. *Trop. Med. Int. Health* 15, 152–159. doi: 10.1111/j.1365-3156.2009.02434.x

Wang, L., Du, F., and Wang, X. (2008). TNF-a induces two distinct caspase-8 activation pathways. *Cell* 133, 693–703. doi: 10.1016/j.cell.2008.03.036

Werts, C. (2017). "Interaction of leptospira with the innate immune system," in *Current Topics in Microbiology and Immunology* (Berlin; Heidelberg: Springer).
Wink, D. A., Hines, H. B., Cheng, R. Y., Switzer, C. H., Flores-Santana, W., Vitek, M. P., et al. (2011). Nitric oxide and redox mechanisms in the immune response. *J. Leukoc. Biol.* 89, 873–891. doi: 10.1189/jlb.1010550

Wynn, T. A. (2015). Type 2 cytokines: mechanisms and therapeutic strategies. *Nat. Rev. Immunol.* 15, 271–282. doi: 10.1038/nri3831

Yamagata, T., Yamagata, Y., Nishimoto, T., Hirano, T., Nakanishi, M., Minakata, Y., et al. (2009). The regulation of amiloride-sensitive epithelial sodium channels by tumor necrosis factor-alpha in injured lungs and alveolar type II cells. *Respir. Physiol. Neurobiol.* 166, 16–23. doi: 10.1016/j resp.2008.12.008

Yilmaz, H., Turhan, V., Yasar, K. K., Hatipoglu, M., Sunbul, M., and Leblebicioglu, H. (2015). Characteristics of leptospirosis with systemic inflammatory response syndrome: a multicenter study. *Ann. Clin. Microbiol. Antimicrob.* 14:54. doi: 10.1186/s12941-015-0117-x

Zeng, L., Gu, W., Chen, K., Jiang, D., Zhang, L., Du, D., et al. (2009). Clinical relevance of the interleukin 10 promoter polymorphisms in Chinese Han patients with major trauma: genetic association studies. *Crit. Care* 13:R188. doi: 10.1186/cc8182

Zhao, H. Q., Li, W. M., Lu, Z. Q., Sheng, Z. Y., and Yao, Y. M. (2015). The growing spectrum of anti-inflammatory interleukins and their potential

roles in the development of sepsis. *J. Interferon Cytokine Res.* 35, 242–251. doi: 10.1089/jir.2014.0119

Zhao, X., Bausano, B., Pike, B. R., Newcomb-Fernandez, J. K., Wang, K. K., Shohami, E., et al. (2001). TNF-alpha stimulates caspase-3 activation and apoptotic cell death in primary septo-hippocampal cultures. *J. Neurosci. Res.* 64, 121–131. doi: 10.1002/jnr.1059

**Conflict of Interest Statement:** The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2018 Cagliero, Villanueva and Matsui. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.